[1] ALFANO P, CUTTITTA G, AUDINO P, et al. Relationship between multimorbidity and quality of life in a primary care setting: the mediating role of dyspnea[J]. J Clin Med, 2022, 11(3):656.
[2] FU Y, CHAPMAN E J, BOLAND A C,et al. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): a practice review[J]. Palliat Med, 2022,36(5):770-782.
[3] ONG K C, EARNEST A, LU S J. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD[J]. Chest,2005,128(6):3810-3816.
[4] 崔海莲.托老机构老年人呼吸系统感染的特点及防治对策[J].基层医学论坛,2013,17(8):956-957.
[5] 李庆华.精细化护理用于老年肺炎患者的临床效果[J].中国医药指南,2019,17(16):258-259.
[6] COVIC A, COPUR S, TAPOI L, et al. Efficiency of hypertonic saline in the management of decompensated heart failure: a systematic review and meta-analysis of clinical studies[J]. Am J Cardiovasc Drugs,2021,21(3):331-347.
[7] WATSON L, VESTBO J, POSTMA D, et al. Gender differences in the management and experiences of chronic obstructive pulmonary disease[J]. Respir Med,2004,98(12):1207-1213.
[8] LARIBI S, KEIJZERS G, VAN MEER O, et al. Epidemiology of patients presenting with dyspnea to emergency departments in Europe and the Asia-Pacific region[J].Eur J Emerg Med, 2019, 26(5): 345-349.
[9] GEDELA M, KHAN M, JONSSON O. Heart failure[J]. S D Med,2015,68(9):403-405, 407-409.
[10] HSIAO R, GREENBERG B. Contemporary treatment of acute heart failure[J]. Prog Cardiovasc Dis,2016,58(4):367-378.
[11] SWEDKERG K,CLELAND J, DARGIE H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology [J]. Eur Heart J,2005,26(11): 1115 -1140.
[12] DONAHOE M. Acute respiratory distress syndrome: a clinical review[J]. Pulm Circ,2011,1(2):192-211.
[13] MATTHAY M A. Challenges in predicting which patients will develop ARDS[J]. Lancet Respir Med, 2016, 4(11):847-848.
[14] KOR D J, CARTER R E, PARK P K, et al. Effect of aspirin on development of ARDS in at- risk patients presenting to the emergency department: the LIPS-A randomized clinical trial[J]. JAMA, 2016, 315 (22):2406-2414.
[15] KELLY C, AGY C, CARLSON M, et al. Family history of venous thromboembolism predicts the diagnosis of acute pulmonary embolism in the emergency department[J]. Am J Emerg Med,2018,36(9):1550-1554.
[16] GAO H, LIU H, LI Y. Value of D dimer levels for the diagnosis of pulmonary embolism: an analysis of 32 cases with computed tomography pulmonary angiography[J]. Exp Ther Med,2018,16(2):1554-1560.
[17] FIELDING-SINGH V, MATTHAY M A, CALFEE C S. Beyond low tidal volume ventilation: treatment adjuncts for severe respiratory failure in acute respiratory distress syndrome[J]. Crit Care Med,2018,46(11):1820-1831.
[18] DRUSANO G L. What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia? [J]. J Antimicrob Chemother,2011,66 Suppl 3:iii61-67.
[19] KONSTANTINIDES S V, T ORBICKI A, AGNELLI G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism [J]. Eur Heart J,2014, 35(43): 3033-3069, 3069a-3069k. |
